Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

Alan Tyndall; Ulrich A. Walker; Andrew Cope; Francesco Dazzi; Cosimo De Bari; Willem Fibbe; Serena Guiducci; Simon Jones; Christian Jorgensen; Katarina Le Blanc; Frank Luyten; Dennis McGonagle; Ivan Martin; Chiara Bocelli-Tyndall; Giuseppina Pennesi; Vito Pistoia; Constantino Pitzalis; Antonio Uccelli; Nico Wulffraat; Marc Feldmann

doi:10.1186/ar2103

Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

Alan Tyndall, Ulrich A. Walker, Andrew Cope, Francesco Dazzi, Cosimo De Bari, Willem Fibbe, Serena Guiducci, Simon Jones, Christian Jorgensen, Katarina Le Blanc, Frank Luyten, Dennis McGonagle, Ivan Martin, Chiara Bocelli-Tyndall, Giuseppina Pennesi, Vito Pistoia, Constantino Pitzalis, Antonio Uccelli, Nico Wulffraat, Marc Feldmann

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article

Abstract

Multipotent mesenchymal stromal cells isolated from bone marrow and other sites are currently being studied to determine their potential role in the pathogenesis and/or management of autoimmune diseases. In vitro studies have shown that they exhibit a dose-dependent antiproliferative effect on T and B lymphocytes, dendritic cells, natural killer cells and various B cell tumour lines - an effect that is both cell contact and soluble factor dependent. Animal models of autoimmune disease treated with multipotent mesenchymal stromal cells have mostly exhibited a positive clinical response, as have a limited number of patients suffering from acute graft versus host disease. This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts.

Original language	English
Article number	301
Journal	Arthritis Research and Therapy
Volume	9
Issue number	3
DOIs	https://doi.org/10.1186/ar2103
Publication status	Published - Jan 29 2007

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1186/ar2103

Fingerprint Dive into the research topics of 'Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005'. Together they form a unique fingerprint.

Cite this

Tyndall, A., Walker, U. A., Cope, A., Dazzi, F., De Bari, C., Fibbe, W., Guiducci, S., Jones, S., Jorgensen, C., Le Blanc, K., Luyten, F., McGonagle, D., Martin, I., Bocelli-Tyndall, C., Pennesi, G., Pistoia, V., Pitzalis, C., Uccelli, A., Wulffraat, N., & Feldmann, M. (2007). Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Research and Therapy, 9(3), [301]. https://doi.org/10.1186/ar2103

Immunomodulatory properties of mesenchymal stem cells : A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. / Tyndall, Alan; Walker, Ulrich A.; Cope, Andrew; Dazzi, Francesco; De Bari, Cosimo; Fibbe, Willem; Guiducci, Serena; Jones, Simon; Jorgensen, Christian; Le Blanc, Katarina; Luyten, Frank; McGonagle, Dennis; Martin, Ivan; Bocelli-Tyndall, Chiara; Pennesi, Giuseppina; Pistoia, Vito; Pitzalis, Constantino; Uccelli, Antonio; Wulffraat, Nico; Feldmann, Marc.

In: Arthritis Research and Therapy, Vol. 9, No. 3, 301, 29.01.2007.

Research output: Contribution to journal › Article

Tyndall, A, Walker, UA, Cope, A, Dazzi, F, De Bari, C, Fibbe, W, Guiducci, S, Jones, S, Jorgensen, C, Le Blanc, K, Luyten, F, McGonagle, D, Martin, I, Bocelli-Tyndall, C, Pennesi, G, Pistoia, V, Pitzalis, C, Uccelli, A, Wulffraat, N & Feldmann, M 2007, 'Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005', Arthritis Research and Therapy, vol. 9, no. 3, 301. https://doi.org/10.1186/ar2103

Tyndall, Alan ; Walker, Ulrich A. ; Cope, Andrew ; Dazzi, Francesco ; De Bari, Cosimo ; Fibbe, Willem ; Guiducci, Serena ; Jones, Simon ; Jorgensen, Christian ; Le Blanc, Katarina ; Luyten, Frank ; McGonagle, Dennis ; Martin, Ivan ; Bocelli-Tyndall, Chiara ; Pennesi, Giuseppina ; Pistoia, Vito ; Pitzalis, Constantino ; Uccelli, Antonio ; Wulffraat, Nico ; Feldmann, Marc. / Immunomodulatory properties of mesenchymal stem cells : A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. In: Arthritis Research and Therapy. 2007 ; Vol. 9, No. 3.

@article{669c4188d85f43c29158c5c9a9df6862,

title = "Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005",

abstract = "Multipotent mesenchymal stromal cells isolated from bone marrow and other sites are currently being studied to determine their potential role in the pathogenesis and/or management of autoimmune diseases. In vitro studies have shown that they exhibit a dose-dependent antiproliferative effect on T and B lymphocytes, dendritic cells, natural killer cells and various B cell tumour lines - an effect that is both cell contact and soluble factor dependent. Animal models of autoimmune disease treated with multipotent mesenchymal stromal cells have mostly exhibited a positive clinical response, as have a limited number of patients suffering from acute graft versus host disease. This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts.",

author = "Alan Tyndall and Walker, {Ulrich A.} and Andrew Cope and Francesco Dazzi and {De Bari}, Cosimo and Willem Fibbe and Serena Guiducci and Simon Jones and Christian Jorgensen and {Le Blanc}, Katarina and Frank Luyten and Dennis McGonagle and Ivan Martin and Chiara Bocelli-Tyndall and Giuseppina Pennesi and Vito Pistoia and Constantino Pitzalis and Antonio Uccelli and Nico Wulffraat and Marc Feldmann",

year = "2007",

month = jan,

day = "29",

doi = "10.1186/ar2103",

language = "English",

volume = "9",

journal = "Arthritis Research and Therapy",

issn = "1478-6354",

publisher = "BioMed Central",

number = "3",

}

TY - JOUR

T1 - Immunomodulatory properties of mesenchymal stem cells

T2 - A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

AU - Tyndall, Alan

AU - Walker, Ulrich A.

AU - Cope, Andrew

AU - Dazzi, Francesco

AU - De Bari, Cosimo

AU - Fibbe, Willem

AU - Guiducci, Serena

AU - Jones, Simon

AU - Jorgensen, Christian

AU - Le Blanc, Katarina

AU - Luyten, Frank

AU - McGonagle, Dennis

AU - Martin, Ivan

AU - Bocelli-Tyndall, Chiara

AU - Pennesi, Giuseppina

AU - Pistoia, Vito

AU - Pitzalis, Constantino

AU - Uccelli, Antonio

AU - Wulffraat, Nico

AU - Feldmann, Marc

PY - 2007/1/29

Y1 - 2007/1/29

N2 - Multipotent mesenchymal stromal cells isolated from bone marrow and other sites are currently being studied to determine their potential role in the pathogenesis and/or management of autoimmune diseases. In vitro studies have shown that they exhibit a dose-dependent antiproliferative effect on T and B lymphocytes, dendritic cells, natural killer cells and various B cell tumour lines - an effect that is both cell contact and soluble factor dependent. Animal models of autoimmune disease treated with multipotent mesenchymal stromal cells have mostly exhibited a positive clinical response, as have a limited number of patients suffering from acute graft versus host disease. This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts.

AB - Multipotent mesenchymal stromal cells isolated from bone marrow and other sites are currently being studied to determine their potential role in the pathogenesis and/or management of autoimmune diseases. In vitro studies have shown that they exhibit a dose-dependent antiproliferative effect on T and B lymphocytes, dendritic cells, natural killer cells and various B cell tumour lines - an effect that is both cell contact and soluble factor dependent. Animal models of autoimmune disease treated with multipotent mesenchymal stromal cells have mostly exhibited a positive clinical response, as have a limited number of patients suffering from acute graft versus host disease. This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts.

UR - http://www.scopus.com/inward/record.url?scp=34547907464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547907464&partnerID=8YFLogxK

U2 - 10.1186/ar2103

DO - 10.1186/ar2103

M3 - Article

AN - SCOPUS:34547907464

VL - 9

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 3

M1 - 301

ER -